VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NBTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
NBTXNanobiotix S.A.
$26.90$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksNBTXBalance Sheet

Nanobiotix S.A. (NBTX) Balance Sheet

15Y historyFree accessUpdated daily

Leverage is elevated, with total liabilities of $161.6M exceeding total assets of $128.3M and total debt of $106.6M producing negative equity of -$33.4M, though a current ratio of 1.44 and $110.8M in cash provide a near-term liquidity buffer.

Income StatementBalance SheetCash FlowRatios

NBTX Balance Sheet

Annual statement

NBTX Balance Sheet

Nanobiotix S.A. (NBTX) balance sheet — 15-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Total Current Assets123.43M62.75M61.47M87.34M52.36M93.06M125.25M46.13M42.65M53.11M26.89M22.95M35.5M6.89M13.54M2.33M
Cash & Short-Term Investments110.85M52.75M49.74M75.28M41.39M84.17M119.15M35.09M36.2M47.21M21.06M17M32.99M5M12.36M898.52K
Cash Only110.85M52.75M49.74M75.28M41.39M83.92M119.15M35.09M36.2M47.21M21.06M17M32.99M5M12.36M898.52K
Short-Term Investments0000000000000000
Accounts Receivable9.37M7.68M8.54M2.97M2.84M3.89M3.88M1.26M997K844K5.21K707.38K62.91K61.79K8.29K1.35M
Days Sales Outstanding-94.57-433.2829.91217.2537.02608.36180.42104.682.770.3564.38.2914.133.12361.3
Inventory000200K2.98M002.67M1.09M-4.9M-5.03M1.21M473.94K199.54K-1.07M87.81K
Days Inventory Outstanding----------------
Other Current Assets02K-1K6.33M2.17M3.04M04.43M5.33M4.73M5.02M4.66M2.04M1.69M00
Total Non-Current Assets4.85M5.01M5.95M6.56M7.41M8.71M8.78M10.08M3.54M4.36M3.51M3.47M1.55M544.95K484.73K580.46K
Property, Plant & Equipment4.41M4.57M5.54M6.11M7.12M8.19M8.26M9.39M2.88M2.99M2.43M2.43M1.29M467.73K416.13K510.79K
Fixed Asset Turnover0.00x6.49x-1.30x5.93x0.67x0.32x0.28x0.27x1.21x1.24x2.23x1.65x2.14x3.41x2.33x2.66x
Goodwill0000000000000000
Intangible Assets7K10K7K8K1K4K21K163K102K135.97K4.45K7.53K9.94K9.07K06.51K
Long-Term Investments0000098K105K131K176K272.93K242.22K218.12K0000
Other Non-Current Assets433.82K434K406K443K291K421K-1K-1K382K000247.35K68.14K68.6K63.16K
Total Assets128.28M67.76M67.42M93.9M59.77M101.77M134.03M56.2M46.2M57.47M30.4M26.42M37.05M7.44M14.02M2.91M
Asset Turnover0.00x0.44x-0.11x0.39x0.08x0.03x0.02x0.05x0.08x0.06x0.18x0.15x0.07x0.21x0.07x0.47x
Asset Growth %108.39%0.51%-28.2%57.1%-41.27%-24.07%138.47%21.67%-19.61%89.02%15.08%-28.7%398.12%-46.96%381.38%-
Total Current Liabilities85.9M57.51M58.94M49.87M37.94M36.84M19.04M14.35M11.6M9.35M8.25M7.1M4.42M3.28M2.16M1.41M
Accounts Payable6.16M6.58M4.48M6.7M4M5M5.57M6.15M4.54M5.14M4.37M3.59M2.23M1.35M279.36K399.82K
Days Payables Outstanding----------------
Short-Term Debt32.05M3.1M3.66M3.82M3.6M7.08M3.67M500K500K770K1.08M1.07M320.97K231.04K360.31K295.44K
Deferred Revenue (Current)126.76M36.22M18.16M18.23M16.57M16.77M07.11M93K2.96M2.23M1.79M1.43M1.04M1.52M719.35K
Other Current Liabilities6.14M430K8.27M760K327K5.39M7.06M-6.7M567K807.47K556.3K-790.5K-778.44K-233.09K577.59K645.81K
Current Ratio1.44x1.09x1.04x1.75x1.38x2.53x6.58x3.22x3.68x5.68x3.26x3.23x8.03x2.10x6.27x1.65x
Quick Ratio1.44x1.09x1.04x1.75x1.30x2.53x6.58x3.03x3.58x6.20x3.87x3.06x7.92x2.04x6.76x1.59x
Cash Conversion Cycle----------------
Total Non-Current Liabilities75.75M94.74M74.19M45.87M48.88M38.13M44.52M43.77M20.36M4.19M4.76M3.7M2.31M974.93K1.17M573.18K
Long-Term Debt73.25M89.12M43.01M41.66M44.04M32.42M39.12M37.62M20.02M3.75M4.58M3.53M2M875.17K1.07M526.77K
Capital Lease Obligations8.51M1.89M2.97M3.88M4.57M5.39M4.99M5.81M00000000
Deferred Tax Liabilities0000000000000000
Other Non-Current Liabilities1.23M3.73M28.21M325K270K318K414K332K334K446.27K175.21K173.91K312.33K99.77K95.37K46.41K
Total Liabilities161.65M152.24M133.12M95.74M86.81M74.98M63.56M58.11M31.95M13.54M13M10.81M6.74M4.26M3.33M1.99M
Total Debt106.57M95.32M50.9M50.56M53.17M46.02M48.98M44.53M20.52M4.73M5.67M4.6M2.32M1.11M1.43M822.21K
Net Debt-4.28M42.57M1.17M-24.72M11.78M-37.9M-70.17M9.43M-15.68M-42.48M-15.39M-12.4M-30.66M-3.9M-10.93M-76.31K
Debt / Equity-3.19x----1.72x0.70x-1.44x0.11x0.33x0.29x0.08x0.35x0.13x0.89x
Debt / EBITDA-1.52x---------------
Net Debt / EBITDA0.06x---------------
Interest Coverage-3.12x-1.30x-8.44x-3.04x-7.83x-67.43x-109.96x-9.76x-35.50x-233.15x-213.84x-288.01x-172.63x-332.90x-66.92x-169.52x
Total Equity-33.37M-84.48M-65.7M-1.84M-27.05M26.79M70.47M-1.91M14.24M43.92M17.4M15.61M30.32M3.18M10.7M925.53K
Equity Growth %-3656.67%-28.58%-3463.07%93.18%-200.95%-61.98%3791.36%-113.4%-67.57%152.45%11.45%-48.5%852.78%-70.25%1055.72%-
Book Value per Share-0.68-1.77-1.39-0.05-0.780.772.89-0.090.732.511.141.102.360.301.300.60
Total Shareholders' Equity-33.37M-84.48M-65.7M-1.84M-27.05M26.79M70.47M-1.91M14.24M43.92M17.4M15.61M30.32M3.18M10.7M925.53K
Common Stock1.52M1.45M1.42M1.41M1.05M1.04M1.03M672K589K589K478.96K424.97K421.94K322.87K322.57K230.32K
Retained Earnings0-23.96M-68.13M-39.7M-57.04M-47M-33.59M-50.91M-30.34M-26.14M-21.88M-17M-9.56M-8.14M-5.33M-5.25M
Treasury Stock-227.91K-228K-228K-228K-228K-202K-196K-169K-124K-27K-57.77K-81.88K-74.49K-221.66K-195.21K0
Accumulated OCI-431.37M-376.14M-311.51M-276.07M-226.58M-182.82M-152.51M-104.64M-78.68M-54.28M-35.44M-20.36M-12.32M-4.33M385.57K-9.66M
Minority Interest0000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Negative equity and cash dependence

Balance Sheet Oscillating Without Durable Repair

According to reported quarterly figures, NBTX's equity swung from a $26.8M surplus in 2021Q4 to a deficit of -$33.4M in 2026Q2, with total liabilities consistently exceeding total assets in most recent periods and no sustained strengthening trend visible.

The pattern suggests the balance sheet has repeatedly been repaired by external inflows and then eroded again by operating losses, rather than strengthening through retained operating profits. Retained earnings remain deeply negative across the window, with the sharp swings in 2024 and 2023 pointing to large non-recurring or milestone-linked movements. Investors should monitor whether the 2026Q2 cash rebuild to $110.8M is sustained or reflects timing of partner-linked receipts.

Debt Load Exceeds Equity Cushion

Based on reported figures, NBTX carried total debt of $106.6M in 2026Q2 against negative equity of -$33.4M, a position where liabilities of $161.6M dwarf the asset base and leave little margin for error on repayment or refinancing.

With debt roughly tripling from $45.1M in 2022Q2 to $106.6M, leverage appears to be expanding faster than the operating base can support, which may reflect necessity-driven rather than strategic borrowing. The negative equity position means debt is not covered by book value, so repayment depends almost entirely on continued access to capital or partner cash. Refinancing terms and maturity schedules are not disclosed in the supplied data and warrant further investigation.

Cash Buffer Thin Against Sustained Burn

As reported in financial statements, NBTX's cash of $110.8M against a current ratio of 1.44 in 2026Q2 provides a near-term buffer, but cash has fluctuated between $21.6M and $83.9M across the window, underscoring dependence on lumpy inflows.

Given quarterly operating cash burn of roughly $22M and free cash flow near -$23M, the reported cash balance covers only a limited number of quarters at current consumption rates. The current ratio improved sharply from 0.63 in 2025Q2 to 1.44 in 2026Q2, which appears driven by a cash rebuild rather than structural working-capital strength. Liquidity headroom therefore looks adequate in the near term but sensitive to the timing of milestone receipts.

Deferred Revenue Anchors Near-Term Recognition

Based on EDBL-style reported figures, NBTX's deferred revenue of $36.2M in 2026Q2, unchanged since 2025Q2, suggests a sizable contracted obligation still being recognized, though the lack of movement signals slow conversion of partner payments into revenue.

A flat deferred revenue balance over several quarters may indicate that recognized revenue is drawing down slowly against previously received upfront cash. This leaves the reported revenue run-rate dependent on the pace of performance obligations that are not quantified in the supplied data. Remaining performance obligation disclosure is absent, so the forward revenue visibility cannot be assessed with confidence.

Cash Rebound May Mask Structural Deficit

Based on reported figures, the 2026Q2 cash increase to $110.8M and current ratio of 1.44 could be read as balance sheet recovery, while negative equity, rising debt, and persistent operating losses point to a structurally strained position.

The headline liquidity improvement may reflect timing of partner-linked receipts rather than a durable change in cash generation, since free cash flow remained negative in the same quarter. Stripping out the cash rebuild, the underlying position of liabilities exceeding assets and debt approaching $107M appears unchanged. Investors should treat the improved current ratio with caution until operating cash flow turns sustainably positive.

NBTX — Frequently Asked Questions

Quick answers to the most common questions about buying NBTX stock.

What are the total assets of Nanobiotix S.A. (NBTX)?

As of 2025, Nanobiotix S.A. (NBTX) had total assets of $67.8M including $62.8M in current assets.

How much debt does Nanobiotix S.A. (NBTX) have?

Nanobiotix S.A. (NBTX) carries total debt of $95.3M, offset by $52.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Nanobiotix S.A.?

Nanobiotix S.A. (NBTX) has total shareholders' equity (book value) of $-84.5M ($-1.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Nanobiotix S.A.'s current ratio and liquidity?

Nanobiotix S.A. (NBTX) reported a current ratio of 1.09x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.